Cellenkos, Inc., a clinical-stage biotechnology company developing tissue-directed, cord blood-derived T-regulatory ...
Rest of World on MSNOpinion
America’s immigration policy is driving away future AI leaders
Visa restrictions are deterring international AI talent from building companies in the U.S., giving other nations including ...
Hungarian Prime Minister Viktor Orbán's 16-year rule ended in the spring, when voters replaced him with Péter Magyar, who has ...
Quantum computing pioneer Pasqal is going public via a merger with the SPAC Bleichroeder Acquisition Corp. II, with ...
NO Nature said it is expanding at home and abroad with All Naerigo, a nitric oxide-based beverage the company says supports ...
Paul Krugman won the Nobel Prize for Economics in 2008 and must be a smart fellow. He wrote on Substack August 11, “The U.S.
Mobilizing high-potential SMEs and entrepreneurial talent could offer nations a path beyond debt and economic stagnation ...
EndoCyclic Therapeutics, Inc., a biopharmaceutical company advancing novel non-hormonal precision peptide therapeutics and diagnostics, today announced it has been nominated for a 2026 Prix Galien USA ...
The Ashland Historical Society received a matching grant from The 1772 Foundation in cooperation with the New Hampshire ...
Craif Inc., a bio-AI company developing a urine analysis platform for early detection of cancer and other diseases, today announced the close of its approximately $33 million* Series D, bringing total ...
Carleton Gajdusek won the Nobel for his work on a disease in Papua New Guinea. But his biggest experiment was on the children ...
Stanford neuroscientist Karl Deisseroth is decoding the human brain to understand how our emotions are formed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results